Clover Biopharmaceuticals, Ltd. (HKG:2197)
Hong Kong · Delayed Price · Currency is HKD 2.160
-0.080 (-3.57%)
Nov 4, 2025, 4:08 PM HKT
Clover Biopharmaceuticals Revenue
Clover Biopharmaceuticals had revenue of 3.25M CNY in the half year ending June 30, 2025, with 1,166.15% growth. This brings the company's revenue in the last twelve months to 51.77M, up 79.16% year-over-year. In the year 2024, Clover Biopharmaceuticals had annual revenue of 38.42M, down -2.13%.
Revenue (ttm)
51.77M CNY
Revenue Growth
+79.16%
P/S Ratio
49.40
Revenue / Employee
172.58K CNY
Employees
300
Market Cap
2.80B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 38.42M | -836.00K | -2.13% |
| Dec 31, 2023 | 39.26M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 71.34B |
| BeOne Medicines AG | 35.81B |
| Sino Biopharmaceutical | 33.49B |
| Alibaba Health Information Technology | 32.81B |
| CSPC Pharmaceutical Group | 28.49B |
| WuXi Biologics | 21.98B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |